In different sample types, NDRG4 methylation has been positively associated with CRC and adenoma, with sensitivity ranging from 27.8% to 81% and specificity from 78.1% to 91.7% [19,20]. This evidence concerns the gene NDRG4 and colorectal carcinoma.